Skin boosters: what the category means and what trials show

"Skin booster" is a category, not a product

This is the first thing to understand, because the term is doing a lot of marketing work. A skin booster is not a specific substance. It is a way of injecting: many shallow deposits spread across an area, intended to change the quality of the skin rather than its shape.

What is in the syringe varies. Most often it is hyaluronic acid in a thin, uncross-linked or lightly cross-linked form. It may instead be polynucleotides, or a mixture including vitamins and other actives. These products have different evidence bases and are not interchangeable, but they are all sold under the same two English words.

So the useful question is never "should I get a skin booster". It is "what exactly are you injecting, and what is the evidence for that".

How it differs from filler

Both are often hyaluronic acid, which is why the confusion persists.

• Filler goes in one place, deeper, in a cohesive gel form, to occupy space and change a contour.
• A booster is spread thinly and shallowly over an area, to change how the skin behaves — hydration, elasticity, fine surface lines.

Same material, entirely different intent. A booster will not build a cheek, and a filler will not improve skin texture across a face.

What the controlled evidence shows

A 2026 multicentre randomised controlled study in Plastic and Reconstructive Surgery — Global Open tested a sodium hyaluronate composite solution given by mesotherapy in 439 participants (287 treated, 152 control). The measurable findings:

• Skin hydration rose by an average of 26.50 units at peak, with a 17.35-point gain still present at three months.
• Skin elasticity rose by an average of 18.18 units at one month, with 11.06 points sustained at three months.
• Adverse events in 1.67% of cases — four of mild to moderate hyperpigmentation and one moderate allergic reaction. None serious.

Those are real, measured, controlled results, and they are the strongest evidence on this page.

How to read the 97% figure

The same study reports a 97.56% efficacy rate against 3.95% in controls, and that number will be quoted at you. It deserves unpacking, because it is true and misleading at the same time.

"Efficacy" there means any improvement on a global aesthetic scale. Inside the treatment group, the distribution was:

Rating	Share of treated patients
Improved	50.87%
Much improved	41.11%
Very much improved	5.57%

So: almost everyone moved, and half of them moved by the smallest measurable amount. "97% of patients improved" and "most patients improved a little" describe the same data.

That is not a criticism of the treatment — a reliable small improvement with a 1.67% adverse event rate is a reasonable thing to buy. It is a caution about the number, which is exactly the sort of figure that ends up on a clinic's English landing page without its distribution.

What a course involves

Boosters are sold as a course: several sessions at intervals, then maintenance. The injections are numerous and shallow, so a topical anaesthetic is usual, and the characteristic short-term effect is small raised bumps at each injection point, with redness and sometimes bruising, settling over days.

Because improvements in the trial were sustained to about three months after the final session, the maintenance interval is not arbitrary — but it does mean the cost is recurring. Ask for the total of the proposed course before starting it, not the price per session.

Questions to ask a Korean clinic

• What exactly is being injected, and what is its Korean product name?
• Which MFDS portal is it licensed on — device or drug?
• Is it hyaluronic acid, polynucleotide, or a mixture? If a mixture, of what?
• How many sessions, at what interval, and what is the total?
• What are you expecting to change, and how will we judge it?

The bottom line

A skin booster is a technique — shallow injections across an area to change skin quality — not a single product, so what matters is what is in the syringe. For hyaluronic acid given this way, a 2026 randomised study of 439 people found measurable gains in hydration and elasticity sustained to three months with adverse events in 1.67%. Its widely quoted 97.56% efficacy rate means almost everyone improved, with half of those at the smallest rung on the scale.